Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Pfizer Study Shows Bivalent Boosters Offer No Short-Term Superiority

Pfizer Study Shows Bivalent Boosters Offer No Short-Term Superiority

-Reuters

byBenzinga Newsdesk

October 25, 2022

1 minute read

-Reuters

University Of Michigan Consumer Sentiment Declines In August, Consumer Expectations Also Fall

By Vandana Singh

August 25, 10:11 AM

The final estimates of the University of Michigan Consumer Sentiment Index show a decline from 71.6 in July to 69.5 in August, below expectations of

SPY

Jefferies Downgrades Provention Bio to Hold, Announces $25 Price Target

By Benzinga Newsdesk

March 14, 5:26 AM

Jefferies analyst Chris Howerton downgrades Provention Bio (NASDAQ:PRVB) from Buy to Hold and announces $25 price target.

PRVB

Anebulo Pharmaceuticals Q1 EPS $(0.11) Down From $(0.07) YoY

By Benzinga Newsdesk

November 10, 9:05 AM

Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.11) per share. This is a 57.14 percent decrease over losses of $(0.07) per share from the same period last year.

ANEB

No UAW Worries, But Tesla Faces Big Labor Union Threat From Striking Dock Workers In Key European Country

By Shanthi Rexaline

November 8, 3:53 AM

Dock workers in Sweden are planning to expand strike against Tesla, which could impact unloading of EVs, reports suggest.

TSLA

Pfizer Study Shows Bivalent Boosters Offer No Short-Term Superiority

Related Posts

University Of Michigan Consumer Sentiment Declines In August, Consumer Expectations Also Fall

Jefferies Downgrades Provention Bio to Hold, Announces $25 Price Target

Anebulo Pharmaceuticals Q1 EPS $(0.11) Down From $(0.07) YoY

No UAW Worries, But Tesla Faces Big Labor Union Threat From Striking Dock Workers In Key European Country